Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma.

Xiao-Xin Wu,Hai-Nv Gao,Hai-Bo Wu,Xiu-Ming Peng,Hui-Lin Ou,Lan-Juan Li
DOI: https://doi.org/10.1016/j.ijid.2015.10.009
IF: 12.073
2015-01-01
International Journal of Infectious Diseases
Abstract:•The mortality rate for avian-origin influenza A (H7N9) infections remains high (52%).•We successfully used convalescent plasma to treat an H7N9 infection in a 45-year-old man.•We are the first to use oseltamivir and convalescent plasma to treat H7N9 in China.
What problem does this paper attempt to address?